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Abstract
Background: With the flood of information generated by the new generation of sequencing
technologies, more efficient bioinformatics tools are needed for in-depth impact analysis of novel
genomic variations. FANS (Functional Analysis of Novel SNPs) was developed to streamline
comprehensive but tedious functional analysis steps into a few clicks and to offer a carefully
designed presentation of results so researchers can focus more on thinking instead of typing and
calculating.
Results: FANS http://fans.ngc.sinica.edu.tw/ harnesses the power of public information databases
and powerful tools from six well established websites to enhance the efficiency of analysis of novel
variations. FANS can process any point change in any coding region or GT-AG splice site to provide
a clear picture of the disease risk of a prioritized variation by classifying splicing and functional
alterations into one of nine risk subtypes with five risk levels.
Conclusion: FANS significantly simplifies the analysis operations to a four-step procedure while
still covering all major areas of interest to researchers. FANS offers a convenient way to prioritize
the variations and select the ones with most functional impact for validation. Additionally, the
program offers a distinct improvement in efficiency over manual operations in our benchmark test.
Background
As sequencing technologies continue to advance rapidly
and the cost of large-scale genotyping and sequencing falls
markedly as a result, there is an increasing need for more
efficient bioinformatics tools with which to analyze the
flood of information regarding novel variations in human
and mouse genomes. For instance, when novel mutations
are found in a cancer genome re-sequencing project or
from Asia Pacific Bioinformatics Network (APBioNet) Seventh International Conference on Bioinformatics (InCoB2008)
Taipei, Taiwan. 20–23 October 2008
Published: 12 December 2008
BMC Bioinformatics 2008, 9(Suppl 12):S10 doi:10.1186/1471-2105-9-S12-S10
<supplement> <title> <p>Seventh International Conference on Bioinformatics (InCoB2008)</p> </title> <editor>Shoba Ranganathan, Wen-Lian Hsu, Ueng-Cheng Yang and Tin Wee Tan</editor> <note>Proceedings</note> </supplement>
This article is available from: http://www.biomedcentral.com/1471-2105/9/S12/S10
© 2008 Liu et al; licensee BioMed Central Ltd. 
This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), 
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.BMC Bioinformatics 2008, 9(Suppl 12):S10 http://www.biomedcentral.com/1471-2105/9/S12/S10
Page 2 of 7
(page number not for citation purposes)
when novel SNPs are pinpointed in a genetic study, a bio-
informatics tool that can efficiently analyze and prioritize
these novel variations for downstream research will surely
save a lot of time and labor. Currently, though many well
developed web projects like SNP@Promoter [1], F-SNP
[2], and Snap [3] provide rich information for functional
SNP prediction and integrated SNP annotation, they can
only process known SNPs rather than newly found ones.
In the analysis of novel variations, the Genomic Mutation
Consequence Calculator (GMCC) [4] does offer some
help to researchers by allowing human mutation analysis
to the synonymous/non-synonymous level. However, to
perform more in-depth impact analysis in human and
mouse genomes, researchers still need to use a suite of
separate online software applications like Rescue-ESE [5]
for candidate exonic splicing enhancers, Fas-ESS [6] for
candidate exonic splicing silencers, SIFT [7] for effects on
protein function, and PolyPhen [8] for structure and func-
tion alterations of a human protein. These analyses of
functional consequences caused by novel variations
require many tedious and error-prone manual steps. To
alleviate this problem, FANS (Functional Analysis of
Novel SNPs) as an extended application of FASTSNP [9]
streamlines information retrieval and functional analysis
for multiple novel SNPs as well as mutations, with versa-
tile input options and a graphical presentation of results,
and provides a great efficiency improvement over manual
operations.
Implementation
Design
According to their location and the kind of genetic altera-
tion they cause, DNA variations are divided into five
groups: non-synonymous, synonymous, splice site,
intronic, and untranslated. Variations classified into the
first three groups are those most likely to have significant
functional impact. The first group may substantially affect
protein function [10]: a non-synonymous variation leads
to an amino acid change or makes a premature stop
codon. Variations of the second [11] and the third catego-
ries [12] can affect pre-mRNA splicing. For better prioriti-
zation, FANS nominates variations as one of five risk
types, with nine risk subtypes and five risk levels (Table 1)
[13,14]. Each analyzed variation is assigned one risk type
and an accompanying risk level. The impact analysis
offered by FANS includes examination of diminished ESE
or ESS, altered protein function, protein domain aboli-
tion, and GT-AG splice site variation. A very important
design feature of FANS is that the analysis is always based
on the most up-to-date data retrieved from the source
websites NCBI (National Center of Biotechnology Infor-
mation) [15], Ensembl [16], UCSC BLAT [17], Rescue-ESE
[5], Fas-ESS [6], and SIFT [7].
Input
Users of FANS can submit a single variation or a batch
query. Currently, FANS offers users the option to search
Table 1: Risk types and risk levels used for prioritization of variations
Group Risk type Risk subtype Possible functional effect Risk level
Non-synonymous Non-sense Causes premature stop codon and affects protein 
function
Very High
Non-synonymous Mis-sense Non-conservative change Predicts to affect protein function High
Non-synonymous Protein domain abolished Changes ESE, ESS and known protein domain and 
results in protein structure abolished
High
Non-synonymous Splicing regulation Changes ESE, ESS but does not change known protein 
domain and results in exon splicing regulation
Medium
Non-synonymous Conservative change Does not change ESE, ESS and known protein domain 
and results in analogous protein structure
Low
Synonymous Splicing regulation Splicing regulation 
(protein domain abolished)
Disrupts exon splicing regulation, make protein domain 
abolished
High
Synonymous Splicing regulation Disrupts exon splicing regulation, make the same 
protein domain
Medium
Synonymous Sense Does not change amino acid and disrupt exon splicing 
regulation
Very Low
Non-coding Splice site Alters GT-AG splice site HighBMC Bioinformatics 2008, 9(Suppl 12):S10 http://www.biomedcentral.com/1471-2105/9/S12/S10
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two species, human and mouse. After choosing the spe-
cies, users need to input a sequence in FASTA format or
provide information for each variation including chromo-
some number, physical position, orientation, and allele
change, either through input fields on the web page or by
uploading a batch file. For a batch file, each variation
occupies a line that must contain the all required informa-
tion for that variation. An example of a batch file is given
online to illustrate the data format accepted by FANS. As
all gene information and prediction results are acquired
through the Internet in real-time, the maximum allowed
number of variations for each batch query is currently 100
to avoid overloading the source websites.
Analysis flow
Figure 1 outlines the analysis flow that is started when a
query is submitted. For a sequence query, the FASTA for-
mat sequence is sent to UCSC BLAT [17] search. FANS
automatically generates the required information about
the novel variations from all the returned BLAT results,
and users only need to choose a group of variations in one
of the BLAT results for the next analysis stage. For each var-
iation, FANS uses the submitted information to search
NCBI Map Viewer to retrieve all transcripts of the gene
covering the variation. If the variation falls in a non-cod-
ing region, it will be checked for its GT-AG splice site risk.
Otherwise, the analysis will translate the coding region
and then follow either a 'synonymous' or a 'non-synony-
mous' flow. A synonymous coding variation which affects
FANS prioritizing and analysis flow path Figure 1
FANS prioritizing and analysis flow path.BMC Bioinformatics 2008, 9(Suppl 12):S10 http://www.biomedcentral.com/1471-2105/9/S12/S10
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amino acid sequence is first subjected to ESE and ESS
analysis. The exonic DNA fragment of eleven nucleotides
centered around the variation is extracted and transmitted
to Rescue-ESE [5] and Fas-ESS [6] for ESE and ESS hexam-
ers pattern matching. Any variation found to be covered
by an ESE or ESS motif that is likely to diminish exon
splicing is subsequently sent to protein domain abolition
analysis. At this stage, FANS utilizes protein domain infor-
mation from NCBI GenPept [18] to check protein domain
abolition that may be caused by splicing regulation when
the diminished exon splicing changes amino acid
sequence in a protein domain.
A non-synonymous variation that produces a stop codon,
resulting in very serious protein structure alteration, is cat-
egorized as risk type "Non-sense" with risk level "Very
High". Other than the "Non-sense" type, FANS takes
advantage of SIFT [7] to see if a particular amino acid
replacement may affect protein function. Those variations
predicted to affect protein function are categorized as
"Mis-sense (non-conservative change)". If no significant
functional impact is found despite the substitution of an
amino acid, then ESE, ESS, and protein domain abolition
analysis will be carried out.
Output
By utilizing retrieved information and analyzed results
from six websites, FANS efficiently prioritizes novel varia-
tions according to their risk levels in a few seconds with
just a few clicks. The integrated results are divided into
four parts for easy visualization: Genome View, Gene
View, Transcript View, and Variation View (Figure 2).
The first screen, Genome View, shows an overview of the
chromosome locations and the risk levels of the queried
variations. The higher the risk level, the warmer the color
that is used, with red color representing a very high risk
level and blue a very low risk. Clicking on a variation label
will move from Genome View to Gene View to display
gene information of that variation. Gene View also dis-
plays the scale, location and all transcripts accommodat-
ing the selected variation. A gene selection list is provided
for a user to choose the gene he/she is interested in. The
transcript accession numbers from NCBI are printed on
the left side of the transcript picture and transcript IDs
from Ensembl are marked on the other side. Users can
link to the source web pages by clicking each ID.
Next, in Transcript View, FANS offers separate transcript
tabs for transcript selection (provided that a gene has
more than one transcript). Gene structure comprising
introns and exons is shown here. Extended exonic regions
together with colored vertical lines are drawn for better
illustration of variation locations. When the mouse is
moved over a line, a pop-up window will show its risk
level and risk type. In addition, an upwards-pointing
arrow further distinguishes the position of the selected
variation.
Finally, Variation View depicts the analysis flow path as
well as the collected results of an analyzed variation.
Selecting an interesting variation out of the variation list
box will bring up its associated results and analysis flow
path. FANS colors the flow path that an analysis has gone
through according to the final risk level outcome. The
highlighted path likewise provides corresponding descrip-
tion pop-up windows when pointed at with the mouse.
Moreover, users can download not only all analyzed
results in CSV format (by clicking the icon right of Tran-
script View) but also a 200 bps flanking sequence of any
variation listed in Variation View.
Development environment
The following software was used to construct FANS:
i. Red Hat Enterprise Linux 4 AS Update 6
ii. Eclipse 3.2.2
iii. Subversion 1.2.1
iv. Tomcat 5.5.20
v. RoboSuite 5.5 SP2
vi. Java SE Development Kit 1.5.0_11
vii. Struts Framework 1.3
viii. BioJava 1.5
Java is the core language for integration and data calcula-
tion from different websites and for the generation of the
final results. BioJava, an open-source project, is used for
amino acid translation. RoboSuite handles the submis-
sion and extraction of data from websites. All develop-
ment processes were done on Eclipse and Subversion was
adopted as our revision control system.
Results
FANS automates analysis flow and simplifies operations
so that researchers can spend more time on thinking
instead of mouse clicking and dragging. Without FANS,
the manual analysis of just a single variation requires a lot
of tedious data extraction and transformation, which is
compounded when there are many to analyze. Major
processing steps include, for example, the retrieval of
intronic and exonic information from every transcript of a
gene covering the variation, the calculation of the position
for translation if the variation occurs in a coding region,BMC Bioinformatics 2008, 9(Suppl 12):S10 http://www.biomedcentral.com/1471-2105/9/S12/S10
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The FANS results page Figure 2
The FANS results page. The output of an analysis of eighteen variations in eight chromosomes.BMC Bioinformatics 2008, 9(Suppl 12):S10 http://www.biomedcentral.com/1471-2105/9/S12/S10
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the extraction of an 11-mer sequence for ESE and ESS
processing, the capture of protein domain information
from NCBI GenPept flat file, the generation of an amino
acid change for the SIFT program, and so on. In a manual
operation benchmarking test, over an hour (3968 s) and
940 discrete steps were needed for a skilled person to
operate all analytic processes over 10 variations in one
gene (APOE). Two fifths of the operations were clicks for
linking and submission, 170 steps were arithmetic, and
others were copy/paste jobs. With FANS, the same analy-
sis took only 118 s and 4 simple steps: selecting a query
type, choosing a species, filling in variation information,
and clicking the submit button, which dramatically
reduced the time required and trimmed the returned
results from forty-seven discrete pages to one single well-
structured web page (Table 2).
Conclusion
FANS is uniquely designed as a convenient way to per-
form in-depth integrated functional analysis of novel var-
iations with always up-to-date data. With the application
of next-generation sequencing platforms such as Roche
GS FLX in genetic association studies or cancer research,
many novel variations in patient samples will be unveiled.
Under these circumstances, FANS offers a convenient way
to prioritize the variations and select the ones with most
functional impact for validation. In addition, more of the
researchers' time and effort can be dedicated to productive
thinking instead of error-prone manual operations. FANS
significantly simplifies the analysis operations to a four-
step procedure while still covering all major areas that
researchers are interested in. Additionally, our benchmark
tests showed that the operation time required for a sample
analysis fell from more than one hour to less than two
minutes. The sequence-based submission allows users to
submit simply a human or a mouse genomic sequence
containing targeted variations. The top-down design of
views and easy data download plus many other intuitive
features should make FANS quite user-friendly to
researchers.
Our future development of this program will include
database localization, an essential step to avoid overload-
ing the websites, and one which should dramatically
shorten processing times. The incorporation of more ana-
lytic tools such as PolyPhen [8] into our analysis flow is
also an important goal in the further development of
FANS.
Availability and requirements
Project name: FANS
Project home page: http://fans.ngc.sinica.edu.tw/
Operation system(s): Platform independent
Programming language: Java
Other requirements: Standard web browser with JavaS-
cript enabled
License: The tool is freely available to academic and non-
academic users.
Any restrictions to use by non-academics: None
List of abbreviations used
SNP: Single Nucleotide Polymorphism; ESE: Exonic Splic-
ing Enhancer; ESS: Exonic Splicing Silencer; UCSC: Uni-
Table 2: A benchmark comparison of analysis of 10 variations by hand and with FANS.
Manual With FANS
Number of Steps Needed NCBI 350 940 4
Ensembl 80
SIFT 100
Rescue-ESE 120
Fas-ESS 120
Calculation 170
Time Taken 3968 s 118 s
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versity of California, Santa Cruz; CSV: Comma Separated
Values.
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